Açık Akademik Arşiv Sistemi
Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria
JavaScript is disabled for your browser. Some features of this site may not work without it.
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
DSpace@Sakarya by Sakarya University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
DSpace@Sakarya:
